scispace - formally typeset
S

Satoru Matsuda

Researcher at Keio University

Publications -  343
Citations -  7697

Satoru Matsuda is an academic researcher from Keio University. The author has contributed to research in topics: Medicine & Esophagectomy. The author has an hindex of 46, co-authored 246 publications receiving 6507 citations. Previous affiliations of Satoru Matsuda include Nagoya University & Osaka University.

Papers
More filters
Journal ArticleDOI

Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells

TL;DR: The results suggest that microglia as well as astrocytes contribute to the integrity of the local environment of NSPCs, and at least IL‐6 and LIF released by activated microglIA promote astroCytic differentiation of N SPCs via the activation of the JAK/STAT and MAPK pathways.
Journal ArticleDOI

In search of a function for the TIS21/PC3/BTG1/TOB family.

TL;DR: It is proposed here to use a nomenclature APRO as a new term for the Btg family of anti‐proliferative gene products, emerging that every member of this family has a potential to regulate cell growth.
Journal Article

Invasion activating caveolin-1 mutation in human scirrhous breast cancers

TL;DR: Genetic evidence that a functioning Caveolin-1 mutation may have a role in the malignant progression of human breast cancer is provided for the first time.
Journal Article

Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity.

TL;DR: Exogenously expressed Tob is able to suppress growth of NIH3T3 cells, but the growth suppression is hampered by the presence of kinase-active p185erbB2, suggesting that other receptor-type protein-tyrosine kinases are also involved in the Tob-mediated regulation of cell growth.
Journal ArticleDOI

The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer

TL;DR: Multivariate analysis revealed that the presence of pneumonia was predictive of poorer overall survival; the multivariate hazard ratio was 1.456 (95% confidence interval 1.020–2.079, P = 0.039).